Bio-Techne (TECH) Net Margin (2009 - 2026)

Bio-Techne's Net Margin history runs 18 years deep, the most recent figure standing at 16.39% for Q1 2026.

• On a quarterly basis, Net Margin rose 925.0% year-over-year to 16.39% in Q1 2026; TTM through Mar 2026 was 1.88%, a 479.0% decrease from a year earlier, with the FY2025 full-year figure at 1.1%, down 1120.0% from the prior year.
• Net Margin improved to 16.39% in Q1 2026 per TECH's latest filing, from 12.85% in the prior quarter.
• Across five years, Net Margin topped out at 4486.7% in Q3 2022 and bottomed at 32.97% in Q2 2025.
• The 5-year median for Net Margin is 16.17% (2024), against an average of 275.3%.
• Across the five-year window, Net Margin surged 445993 bps in 2022 and plunged 446829 bps in 2023, its largest moves.
• Year by year, Net Margin stood at 18.41% in 2022, then tumbled by 45 bps to 10.08% in 2023, then increased by 17 bps to 11.75% in 2024, then gained by 9 bps to 12.85% in 2025, then advanced by 28 bps to 16.39% in 2026.
• Per Business Quant, the three latest TECH Net Margin figures stand at 16.39% (Q1 2026), 12.85% (Q4 2025), and 13.33% (Q3 2025).